371 related articles for article (PubMed ID: 6119681)
41. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
Erzin-Waters C; Muller P; Seeman P
Can J Physiol Pharmacol; 1976 Aug; 54(4):516-9. PubMed ID: 10058
[TBL] [Abstract][Full Text] [Related]
42. Central action of ergometrine.
Antkiewicz-Michaluk L
Pol J Pharmacol Pharm; 1976; 28(6):563-70. PubMed ID: 1034920
[TBL] [Abstract][Full Text] [Related]
43. Central action of phenylethylamine in rats.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
[TBL] [Abstract][Full Text] [Related]
44. Influence of albumin degradation products (ADP) on the central action of catecholamines.
Tarasiewicz S; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926
[TBL] [Abstract][Full Text] [Related]
45. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
Olds ME; Jacques DB; Kopyov O
Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
[TBL] [Abstract][Full Text] [Related]
46. [Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine). Effects of eptazocine on spontaneous movements].
Sakakibara S
Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):549-63. PubMed ID: 6618345
[TBL] [Abstract][Full Text] [Related]
47. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
48. The effect of collagen degradation products (CDP) on the central dopaminergic system.
Telejko E; Maćkowiak J; Wiśniewski K
Acta Physiol Pol; 1990; 41(7):127-37. PubMed ID: 2136307
[TBL] [Abstract][Full Text] [Related]
49. Flunixin meglumine: a non-narcotic analgesic.
Ciofalo VB; Latranyi MB; Patel JB; Taber RI
J Pharmacol Exp Ther; 1977 Mar; 200(3):501-7. PubMed ID: 850126
[TBL] [Abstract][Full Text] [Related]
50. [Influence of adrenergic-blocking agents on the pain-alleviating effect of narcotic analgesics].
Slivko SF; Stets VR
Farmakol Toksikol; 1978; 41(5):544-8. PubMed ID: 29777
[TBL] [Abstract][Full Text] [Related]
51. Sedative action of low doses of dopaminergic agents.
Maj J; Przewlocka B; Kukulka L
Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
[TBL] [Abstract][Full Text] [Related]
52. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
53. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
Churiukanov VV
Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
[TBL] [Abstract][Full Text] [Related]
54. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
Wasik A; Romańska I; Antkiewicz-Michaluk L
J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
[TBL] [Abstract][Full Text] [Related]
55. Effect of narcotic analgesics on the striatal homovanillic acid content in mice; relation to antinociceptive effect.
Kääriäinen I; Ahtee L
Med Biol; 1976 Feb; 54(1):56-61. PubMed ID: 4679
[TBL] [Abstract][Full Text] [Related]
56. Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats.
Hoffmann VL; Baker AK; Vercauteren MP; Adriaensen HF; Meert TF
Eur J Pain; 2003; 7(2):121-30. PubMed ID: 12600793
[TBL] [Abstract][Full Text] [Related]
57. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
58. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
[TBL] [Abstract][Full Text] [Related]
59. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
[TBL] [Abstract][Full Text] [Related]
60. [The effect of narcotic analgesics on the central nervous system as an index of their drug addiction potential].
Bantutova I; Iakimova K
Farmakol Toksikol; 1991; 54(1):21-3. PubMed ID: 1677621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
